Breast cancer gene-expression blood test

Thursday, 01 January, 2009 | Supplied by: Applied Biosystems Pty Ltd



DiaGenic and Applied Biosystems have launched BCtect, a blood-based test for early detection of breast cancer. The test searches for a unique gene expression signature using a custom TaqMan array.

The test uses peripheral blood rather than tissue from the actual breast, providing a less invasive method of testing. It is also not affected by ethnic variation or the menopausal state of the patient, allowing for widespread use to diagnose breast cancer at an early stage.

The TaqMan Array consists of 96 TaqMan gene expression assays pre-loaded multiple times on a 384-well microfluidic card. These 384 simultaneous, real-time PCR reactions are performed without the need to use liquid-handling robots or multichannel pipettors. The array is run on the 7900HT Fast Real-time PCR System by Labindia.

 

Online: www.appliedbiosystems.com
Phone: 03 9730 8600
Related Products

Cayman Chemical SARS-CoV-2 Neutralizing Antibody Detection ELISA Kit

Cayman Chemical's SARS-CoV-2 Neutralizing Antibody Detection ELISA Kit is a competitive assay...

DMT Starter System tissue organ bath system for education

The sleek Starter System by DMT is a tissue organ bath that teaches students about the variation...

PCR Biosystems RiboShield RNase Inhibitor

PCR Biosystems' RiboShield RNase Inhibitor is now available as a standalone product. The...


  • All content Copyright © 2020 Westwick-Farrow Pty Ltd